Clinical Trials on Acute Respiratory Failure in China

Total 7100 results

CardioKinetix, Inc
Peking University; Guangzhou Chuangsi Medical Technology Co., Ltd.

Terminated

PARACHUTE China Approval Trial

Ischemic Heart Failure

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAML

Secondary Acute Myeloid Leukemia

China
Guangdong Provincial People's Hospital

Withdrawn

Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor (CoVac-Lung)

Vaccine Adverse Reaction | Lung Cancer | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | Pulmonary Nodule, Solitary | Pulmonary Nodule, Multiple

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT (VMAC+DLI)

Relapse Acute Myeloid Leukemia

China
Imbioray (Hangzhou) Biomedicine Co., Ltd.
The First Affiliated Hospital of Soochow University

Not yet recruiting

Study of IBR733 Cell Injection in Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
The First Affiliated Hospital with Nanjing Medical...
Huai'an First People's Hospital; Yancheng First People's Hospital

Recruiting

Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML

Acute Myeloid Leukemia

China
920th Hospital of Joint Logistics Support Force...
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML

Acute Myeloid Leukemia

China
The First Affiliated Hospital of Soochow University

Recruiting

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Acute Myeloid Leukemia (Relapsed/Refractory)

China
Xuzhou Medical University

Recruiting

Safety and Efficacy of Allogenic NK Cells in Combination With Chemotherapy in the Treatment of r/r AML After Allo-HSCT

Acute Myeloid Leukemia

China
Zhujiang Hospital

Recruiting

Single Arm Study of Azacitidine and Venetoclax for Treatment of Newly Diagnosed Fit Acute Myeloid Leukemia Patients

Leukemia, Myeloid, Acute

China
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid

Acute Myeloid Leukemia

China
The First Affiliated Hospital with Nanjing Medical...
Huai'an First People's Hospital; Yancheng First People's Hospital; The Affiliated...

Recruiting

Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

Acute Myeloid Leukemia

China
Zhejiang University
Yake Biotechnology Ltd.

Not yet recruiting

IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Zhejiang University
First People's Hospital of Hangzhou; Second Affiliated Hospital, School of... and other collaborators

Recruiting

Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

China
Huihan Wang

Recruiting

D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

Acute Myeloid Leukemia

China
Shanghai Unicar-Therapy Bio-medicine Technology...

Recruiting

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

China
Wuhan Union Hospital, China
Jinan University, China

Unknown

Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia

Acute Myeloid Leukemia

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Yanda Ludaopei Hospital

Unknown

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia

Acute Myelocytic Leukemia

China
Shandong University

Unknown

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Acute Myeloid Leukemia

China
Nanfang Hospital of Southern Medical University
Pfizer

Unknown

Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients

Acute Myeloid Leukemia

China
The Affiliated Hospital of the Chinese Academy...

Recruiting

Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia

Safety Issues | Efficiency

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML

Acute Myeloid Leukemia | Core-Binding Factor

China
The First Affiliated Hospital of Nanchang University

Unknown

Follow-up Study of Complications of Acute Pancreatitis (FSCAP)

Metabolic Diseases | Quality of Life | Respiratory Failure | Pancreatic Neoplasms | Hypertension, Portal | Pancreatitis

China
Shanghai Jiao Tong University School of Medicine
Shanghai Clinical Research Center

Recruiting

Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia

APL

China
Hematology department of the 920th hospital

Recruiting

Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia

Refractory/Relapse Acute Myeloid Leukemia

China
Yuguo Chen
Qilu Hospital of Shandong University; Qianfoshan Hospital; Jining Medical University and other collaborators

Completed

The Evaluation and Management of Patients With Acute ChesT Pain in China (EMPACT)

Acute Coronary Syndrome | Acute Chest Pain

China
Yong Lin, PhD

Recruiting

Driving Pressure-guided Lung Protective Ventilation (DPV)

Hypoxemia | Ventilator Lung

China
Capital Medical University
Shanghai 10th People's Hospital; Second Affiliated Hospital of Nanchang University and other collaborators

Completed

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

Stroke, Acute | Neuroprotection

China
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

The Clinical Efficiency of Tb-ERA in Chinese RIF Patients

Endometrial Receptivity | Repeated Implantation Failure

China
The Children's Hospital of Zhejiang University...
College of Pharmaceutical Science at Zhejiang University

Recruiting

Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test

Acute Myeloid Leukemia in Children

China
Nanjing Chia-tai Tianqing Pharmaceutical

Recruiting

A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies

Relapsed/Refractory Acute Myeloid Leukemia (AML)

China
Tianjin Nankai Hospital

Completed

A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis

Acute Pancreatitis

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis

Anemia | Chronic Renal Failure

China
wang, jianxiang

Recruiting

Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia

Acute Myeloid Leukemia | CEBPA Double Mutation

China
Lee's Pharmaceutical Limited
Zhaoke (Hefei) Pharmaceutical Limited

Completed

A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children

Anesthesia, Local | Pain, Acute | Catheter Site Pain

China
Chinese PLA General Hospital

Recruiting

Role of aGVHD Biomarkers on aGVHD Risks (GVHD)

Biomarker | GVHD,Acute

China
Peking University Third Hospital
Shanghai Jiao Tong University School of Medicine

Active, not recruiting

Microbial Markers for AGI

Acute Gastrointestinal Injury

China
Capital Medical University

Completed

Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke

Stroke, Acute

China
The First Affiliated Hospital of Soochow University

Recruiting

Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML (VHA)

Acute Myeloid Leukemia

China
Hematology department of the 920th hospital

Recruiting

A Clinical Study of VA-CAG as Induction Therapy in Newly Diagnosed AML Patients

Acute Myeloid Leukemia

China
Huihan Wang

Recruiting

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

Acute Myeloid Leukemia

China
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Donor Immune Cell Therapy for Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Wuxi People's Hospital
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
LanZhou University

Recruiting

Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML

Acute Myeloid Leukemia

China
LanZhou University
Beijing Health Alliance Charitable Foundation

Recruiting

Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Akeso

Recruiting

A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
The First Affiliated Hospital of Soochow University

Recruiting

Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

China
Zhejiang University
Yake Biotechnology Ltd.

Not yet recruiting

NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
The First Affiliated Hospital of Soochow University

Recruiting

CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
The First Affiliated Hospital of Soochow University

Unknown

Prognostic Values of Next Generation Sequencing (NGS) in Acute Myeloid Leukemia Patients With Allo-HSCT

Acute Myeloid Leukemia

China

Clinical Trials on Acute Respiratory Failure in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations